Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    RTOG-0834
Show Display Options
Rank Status Study
1 Active, not recruiting Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide;   Genetic: DNA methylation analysis;   Other: laboratory biomarker analysis;   Procedure: adjuvant therapy;   Procedure: quality-of-life assessment;   Radiation: radiation therapy

Indicates status has not been verified in more than two years